DRTECH Corporation (KOSDAQ:214680)
1,681.00
+42.00 (2.56%)
Apr 1, 2026, 3:30 PM KST
DRTECH Revenue
DRTECH had revenue of 34.04B KRW in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 120.30B, up 28.93% year-over-year. In the year 2024, DRTECH had annual revenue of 97.56B with 5.54% growth.
Revenue (ttm)
120.30B
Revenue Growth
+28.93%
P/S Ratio
1.21
Revenue / Employee
320.40M
Employees
363
Market Cap
140.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 97.56B | 5.12B | 5.54% |
| Dec 31, 2023 | 92.44B | 2.96B | 3.31% |
| Dec 31, 2022 | 89.48B | 19.20B | 27.33% |
| Dec 31, 2021 | 70.28B | 15.01B | 27.16% |
| Dec 31, 2020 | 55.27B | 7.42B | 15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InBody Co.,Ltd | 233.95B |
| Osang Healthcare Co.,Ltd | 128.63B |
| Ray Co., Ltd. | 111.32B |
| Bio Plus | 90.90B |
| LabGenomics | 89.36B |
| T&R Biofab | 26.97B |
| HASS Corp. | 16.59B |
| Sugentech | 9.42B |